Takeda Pharmaceutical Co. Ltd. · TSE:4502

Duprey Lauren Rusckowski received 59,990 Takeda Pharmaceutical Co. Ltd. shares as an award (Form 4)

Traded Apr 27, 2026 · Filed Apr 28, 2026

On Apr 27, 2026, Duprey Lauren Rusckowski (Chief Transformation Officer) received 59,990 Takeda Pharmaceutical Co. Ltd. shares as an award, leaving 228,503 shares. Filed Apr 28, 2026 (Form 4).

Awarded
59,990 shares
Holding after
228,503 shares
Trading plan
No
Role
Chief Transformation Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 27, 2026American Depositary SharesAward59,990228,503Direct

Source

View original at SEC

Related